Literature DB >> 31863595

A fast score test for generalized mixture models.

Rui Duan1, Yang Ning2, Shuang Wang3, Bruce G Lindsay4, Raymond J Carroll5, Yong Chen1.   

Abstract

In biomedical studies, testing for homogeneity between two groups, where one group is modeled by mixture models, is often of great interest. This paper considers the semiparametric exponential family mixture model proposed by Hong et al. (2017) and studies the score test for homogeneity under this model. The score test is nonregular in the sense that nuisance parameters disappear under the null hypothesis. To address this difficulty, we propose a modification of the score test, so that the resulting test enjoys the Wilks phenomenon. In finite samples, we show that with fixed nuisance parameters the score test is locally most powerful. In large samples, we establish the asymptotic power functions under two types of local alternative hypotheses. Our simulation studies illustrate that the proposed score test is powerful and computationally fast. We apply the proposed score test to an UK ovarian cancer DNA methylation data for identification of differentially methylated CpG sites.
© 2019 The International Biometric Society.

Entities:  

Keywords:  DNA methylation; asymptotics; conditional likelihood; nonregular problem; semiparametric mixture model

Year:  2019        PMID: 31863595      PMCID: PMC7424630          DOI: 10.1111/biom.13204

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  27 in total

1.  Hypothesis testing under mixture models: application to genetic linkage analysis.

Authors:  K Y Liang; P J Rathouz
Journal:  Biometrics       Date:  1999-03       Impact factor: 2.571

2.  Genetic variability in residual variation of body weight and conformation scores in broiler chickens.

Authors:  A Wolc; I M S White; S Avendano; W G Hill
Journal:  Poult Sci       Date:  2009-06       Impact factor: 3.352

3.  Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype.

Authors:  Song Yi Ko; Andras Ladanyi; Ernst Lengyel; Honami Naora
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

4.  Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.

Authors:  Hongjun Wang; Ying Feng; Zhaoshi Bao; Chuanlu Jiang; Wei Yan; Yongzhi Wang; Chuanbao Zhang; Yanwei Liu; Quangeng Zhang; Wei Zhang; Chuanlu Jiang
Journal:  Oncol Rep       Date:  2013-08-29       Impact factor: 3.906

5.  Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.

Authors:  Ulises Urzúa; Katherine F Roby; Lisa M Gangi; James M Cherry; John I Powell; David J Munroe
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

6.  MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5.

Authors:  Alexander I Damanakis; Sabine Eckhardt; Annette Wunderlich; Silvia Roth; Thaddeus T Wissniowski; Detlef K Bartsch; Pietro Di Fazio
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-09       Impact factor: 4.553

7.  Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients.

Authors:  Wei-Jia Fang; Yi Zheng; Li-Ming Wu; Qing-Hong Ke; Hong Shen; Ying Yuan; Shu-Sen Zheng
Journal:  Asian Pac J Cancer Prev       Date:  2012

8.  Genomic outlier profile analysis: mixture models, null hypotheses, and nonparametric estimation.

Authors:  Debashis Ghosh; Arul M Chinnaiyan
Journal:  Biostatistics       Date:  2008-06-06       Impact factor: 5.899

9.  The role of KCNQ1 in mouse and human gastrointestinal cancers.

Authors:  B L N Than; J A C M Goos; A L Sarver; M G O'Sullivan; A Rod; T K Starr; R J A Fijneman; G A Meijer; L Zhao; Y Zhang; D A Largaespada; P M Scott; R T Cormier
Journal:  Oncogene       Date:  2013-08-26       Impact factor: 9.867

10.  Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

Authors:  Sjoerd H den Uil; Veerle M H Coupé; Janneke F Linnekamp; Evert van den Broek; Jeroen A C M Goos; Pien M Delis-van Diemen; Eric J Th Belt; Nicole C T van Grieken; Patricia M Scott; Louis Vermeulen; Jan Paul Medema; Herman Bril; Hein B A C Stockmann; Robert T Cormier; Gerrit A Meijer; Remond J A Fijneman
Journal:  Br J Cancer       Date:  2016-11-17       Impact factor: 7.640

View more
  1 in total

1.  BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA®-Coded Adverse Events in Randomized Controlled Trials.

Authors:  Alma Revers; Michel H Hof; Aeilko H Zwinderman
Journal:  Drug Saf       Date:  2022-07-15       Impact factor: 5.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.